Try our Advanced Search for more refined results
June 28, 2023
Alkermes Pharma Ireland Limited v. Janssen Pharmaceutica N.V.
Case Number:
1:23-cv-05542
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 18, 2023
Alkermes Gets $194M Award Against Janssen Approved
A New York federal judge on Friday confirmed an unopposed arbitration award against Janssen Pharmaceutical N.V. that required the Johnson & Johnson subsidiary to pay more than $194 million in back royalties to Alkermes Pharma Ireland Ltd., ending a legal dispute over licensing agreements between the companies.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login